The Discounted Cash Flow (DCF) valuation of Amphastar Pharmaceuticals Inc (AMPH) is 34.15 USD. With the latest stock price at 19.23 USD, the upside of Amphastar Pharmaceuticals Inc based on DCF is 77.6%.
Based on the latest price of 19.23 USD and our DCF valuation, Amphastar Pharmaceuticals Inc (AMPH) is a buy. buying AMPH stocks now will result in a potential gain of 77.6%.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 9.1% | 7.6% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 21.86 - 66.11 | 34.15 |
| Upside | 13.7% - 243.8% | 77.6% |